MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2017 Sep 20

PMID 28924964

Citations 19

Authors

Weiqing Chen

Lijun Ye

Dengcheng Wen

Feihua Chen

Affiliations

Soon will be listed here.

Abstract

Studies have investigated the effect of ROBO1. All the same, the relationship between miR-490-5p and ROBO1, and the underlying mechanism are still unclear. We aimed to study the effect of microRNA-490-5p (miR-490-5p) on hepatocellular carcinoma (HCC) cell proliferation, migration and invasion by directly regulating ROBO1. The expression of miR-490-5p and ROBO1 in HCC tissues and cells were tested by RT-qPCR, and the Hep3B cells were selected for subsequent experiments. We confirmed the relationship between miR-490-5p and ROBO1 by luciferase reporter system. The effects of miR-490-5p on cell proliferation, migration and invasion of Hep3B cells were assessed by MTT assay, colony formation assay, wound healing assay and transwell assay, respectively. Flow cytometry was employed to detect the influence of miR-490-5p on cell cycle and apoptosis of Hep3B cells. The expression of miR-490-5p was down-regulated, while ROBO1 was up-regulated in HCC tissues and cells than the controls. MiR-490-5p can target ROBO1. MiR-490-5p inhibited cell proliferation, migration and invasion, but promoted cell apoptosis of Hep3B cells by inhibiting ROBO1. We confirmed that miR-490-5p could directly suppress ROBO1, which might be a potential mechanism in inhibiting HCC cell proliferation, migration and invasion.

Citing Articles

[Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer].

Cong J, Wang A, Wang Y, Li X, Pi J, Liu K Zhongguo Fei Ai Za Zhi. 2025; 27(12):919-930.

PMID: 39962847 PMC: 11839496. DOI: 10.3779/j.issn.1009-3419.2024.102.43.

Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.

Wei S, Tan J, Huang X, Zhuang K, Qiu W, Chen M J Transl Med. 2024; 22(1):711.

PMID: 39085893 PMC: 11293133. DOI: 10.1186/s12967-024-05493-0.

The SLIT/ROBO Pathway in Liver Fibrosis and Cancer.

Basha S, Jin-Smith B, Sun C, Pi L Biomolecules. 2023; 13(5).

PMID: 37238655 PMC: 10216401. DOI: 10.3390/biom13050785.

Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network.

Yi J, Wen Z, Hu Y Contrast Media Mol Imaging. 2022; 2022:6716324.

PMID: 36299828 PMC: 9576451. DOI: 10.1155/2022/6716324.

Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma.

Liu J, Lu J, Li W, Mao W, Lu Y Front Genet. 2022; 13:900380.

PMID: 35836576 PMC: 9273781. DOI: 10.3389/fgene.2022.900380.

References

Ito H, Funahashi S, Yamauchi N, Shibahara J, Midorikawa Y, Kawai S . Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res. 2006; 12(11 Pt 1):3257-64. DOI: 10.1158/1078-0432.CCR-05-2787. View

Viswanathan S, Powers J, Einhorn W, Hoshida Y, Ng T, Toffanin S . Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009; 41(7):843-8. PMC: 2757943. DOI: 10.1038/ng.392. View

Kota J, Chivukula R, ODonnell K, Wentzel E, Montgomery C, Hwang H . Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009; 137(6):1005-17. PMC: 2722880. DOI: 10.1016/j.cell.2009.04.021. View

Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S . MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009; 361(15):1437-47. PMC: 2786938. DOI: 10.1056/NEJMoa0901282. View

Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S . MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010; 6(3):e1000879. PMC: 2837402. DOI: 10.1371/journal.pgen.1000879. View

Niemoeller O, Niyazi M, Corradini S, Zehentmayr F, Li M, Lauber K . MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol. 2011; 6:29. PMC: 3079656. DOI: 10.1186/1748-717X-6-29. View

Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L . MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 2011; 6(3):e18286. PMC: 3065473. DOI: 10.1371/journal.pone.0018286. View

Nakatani F, Ferracin M, Manara M, Ventura S, Del Monaco V, Ferrari S . miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol. 2011; 226(5):796-805. DOI: 10.1002/path.3007. View

Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides G, Jaeger S . An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011; 147(6):1233-47. PMC: 3251960. DOI: 10.1016/j.cell.2011.10.043. View

10.

Kang Y, Zhang Z, Zhang H, Duan X, Liu J, Li X . Expression of microRNAs during chondrogenesis of human adipose-derived stem cells. Osteoarthritis Cartilage. 2012; 20(12):1638-46. DOI: 10.1016/j.joca.2012.08.024. View

11.

Zhang L, Liu M, Li X, Tang H . miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem. 2012; 288(6):4035-47. PMC: 3567655. DOI: 10.1074/jbc.M112.410506. View

12.

Li S, Xu X, Xu X, Hu Z, Wu J, Zhu Y . MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochem Biophys Res Commun. 2013; 441(4):976-81. DOI: 10.1016/j.bbrc.2013.11.006. View

13.

Allen M, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E . Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res. 2013; 74(3):896-907. DOI: 10.1158/0008-5472.CAN-13-1702. View

14.

Parray A, Siddique H, Kuriger J, Mishra S, Rhim J, Nelson H . ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models. Int J Cancer. 2014; 135(11):2493-506. PMC: 4610361. DOI: 10.1002/ijc.28919. View

15.

Chinn G, Hirokawa K, Chuang T, Urbina C, Patel F, Fong J . Agenesis of the Corpus Callosum Due to Defective Glial Wedge Formation in Lhx2 Mutant Mice. Cereb Cortex. 2014; 25(9):2707-18. PMC: 4537429. DOI: 10.1093/cercor/bhu067. View

16.

Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag M, Kolanowska M . Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. Int J Biochem Cell Biol. 2014; 53:208-17. DOI: 10.1016/j.biocel.2014.05.020. View

17.

Gara R, Kumari S, Ganju A, Yallapu M, Jaggi M, Chauhan S . Slit/Robo pathway: a promising therapeutic target for cancer. Drug Discov Today. 2014; 20(1):156-64. PMC: 4445861. DOI: 10.1016/j.drudis.2014.09.008. View

18.

Shen J, Xiao Z, Wu W, Wang M, To K, Chen Y . Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res. 2014; 75(4):754-65. DOI: 10.1158/0008-5472.CAN-14-1301. View

19.

Kim S, Lee K, Kim D, Kwak E, Kim S, Kim K . Rhythmic control of mRNA stability modulates circadian amplitude of mouse Period3 mRNA. J Neurochem. 2015; 132(6):642-56. DOI: 10.1111/jnc.13027. View

20.

Loo J, Scherl A, Nguyen A, Man F, Weinberg E, Zeng Z . Extracellular metabolic energetics can promote cancer progression. Cell. 2015; 160(3):393-406. PMC: 4312495. DOI: 10.1016/j.cell.2014.12.018. View